COVID-19 UPDATES: Click here to read more!
Click here to get on our COVID-19 Waiting List

Get Healthy!

  • Posted November 11, 2024

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

Health News is provided as a service to Seip Drug site users by HealthDay. Seip Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.